Drug Trial Radar · NCT04544774
The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jul 16, 2020
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Universitaire Ziekenhuizen KU LeuvenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- AZ Sint-Jan AV
- First posted
- Sep 10, 2020
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
Summary
As written by the sponsor on the registry.
This prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy. The NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone contacts that are repeated annually for 3 years. This study will be conducted in 2 hospitals: UZ Leuven and AZ ST. Jan Brugge on the consultation Ear, Nose and Throat Diseases (ENT) and the department of Internal Medicine / Allergology
Conditions
- Perennial Allergic Rhinitis
- Seasonal Allergic Rhinitis
- Local Allergic Rhinitis
Interventions
AITDrug
AIT for airborn allergens (SCIT/SLIT)
NAPTDiagnostic test
NAPT test with airborn allergens ( HDM, Threes, Grasses)
Primary outcomes
What the sponsor says the trial is designed to measure.
- The effectiveness of AIT treatment assessed by the change in the blood concentration in total en specific IgE .Time frame: before start AIT, every 6 months en after 3 years
- The effectiveness of AIT treatment assessed by the change in quality of life meassured by the Lebelscore.Time frame: Before start AIT, every 6 months en after 3 years
- The effectiveness of AIT treatment assessed by the change in quality of life meassured by the SNOT-22.Time frame: Before start AIT, every 6 months en after 3 years
- The effectiveness of AIT treatment assessed by the change in quality of life meassured by the VAS.Time frame: Before start AIT, every 6 months en after 3 years
- The effectiveness of AIT treatment assessed by the change in quality of life meassured by the TNSS.Time frame: Before start AIT, every 6 months en after 3 years
- The effectiveness of AIT treatment assessed by the change in quality of life meassured by the ACT.Time frame: Before start AIT, every 6 months en after 3 years
- The effectiveness of AIT treatment assessed by the change in quality of life meassured by the RQLQ.Time frame: Before start AIT, every 6 months en after 3 years
- The effectiveness of AIT treatment assessed by the change in quality of life meassured by the TRE.Time frame: Before start AIT, every 6 months en after 3 years
- The effectiveness of AIT treatment assessed by the change in the PNIF value.Time frame: Before start AIT, every 6 months en after 3 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
AZ Sint-Jan
Bruges, Belgium · Not yet recruiting
UZ Leuven
Leuven, Vlaam Brabant, Belgium · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.